Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M75,964Revenue $M6,932Net Margin (%)27.8Z-Score16.5
Enterprise Value $M74,693EPS $7.8Operating Margin %38.4F-Score8
P/E(ttm))30.4Cash Flow Per Share $7.4Pre-tax Margin (%)38.2Higher ROA y-yY
Price/Book7.310-y EBITDA Growth Rate %25.7Quick Ratio1.9Cash flow > EarningsY
Price/Sales8.55-y EBITDA Growth Rate %20.1Current Ratio2.3Lower Leverage y-yY
Price/Cash Flow20.5y-y EBITDA Growth Rate %51.4ROA % (ttm)20.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)27.3Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M236ROI % (ttm)19.7Gross Margin Increase y-yN

Gurus Latest Trades with BIIB

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIIBKen Fisher 2014-06-30 Add0.05%$274 - $320.13
($300.74)
$ 321.677%Add 386.61%88,885
BIIBRon Baron 2014-06-30 Add$274 - $320.13
($300.74)
$ 321.677%Add 41.76%8,632
BIIBKen Heebner 2014-06-30 Sold Out -0.95%$274 - $320.13
($300.74)
$ 321.677%Sold Out0
BIIBAndreas Halvorsen 2014-06-30 Sold Out -0.5%$274 - $320.13
($300.74)
$ 321.677%Sold Out0
BIIBJoel Greenblatt 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 321.677%Sold Out0
BIIBGeorge Soros 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 321.677%Sold Out0
BIIBJohn Burbank 2014-06-30 Sold Out -0.01%$274 - $320.13
($300.74)
$ 321.677%Sold Out0
BIIBKen Heebner 2014-03-31 Buy 0.95%$273.518 - $351.94
($316.4)
$ 321.672%New holding, 116000 sh.116,000
BIIBAndreas Halvorsen 2014-03-31 Buy 0.5%$273.518 - $351.94
($316.4)
$ 321.672%New holding, 388900 sh.388,900
BIIBGeorge Soros 2014-03-31 Buy 0.02%$273.518 - $351.94
($316.4)
$ 321.672%New holding, 7500 sh.7,500
BIIBJoel Greenblatt 2014-03-31 Buy 0.02%$273.518 - $351.94
($316.4)
$ 321.672%New holding, 3931 sh.3,931
BIIBRon Baron 2014-03-31 Buy 0.01%$273.518 - $351.94
($316.4)
$ 321.672%New holding, 6089 sh.6,089
BIIBJohn Burbank 2014-03-31 Buy 0.01%$273.518 - $351.94
($316.4)
$ 321.672%New holding, 783 sh.783
BIIBKen Fisher 2014-03-31 Add0.01%$273.518 - $351.94
($315.54)
$ 321.672%Add 796.27%18,266
BIIBVanguard Health Care Fund 2014-03-31 Reduce-0.24%$273.518 - $351.94
($315.54)
$ 321.672%Reduce -32.19%599,400
BIIBRay Dalio 2014-03-31 Sold Out -0.04%$273.518 - $351.94
($316.4)
$ 321.672%Sold Out0
BIIBRay Dalio 2013-12-31 Add0.03%$223.85 - $295.88
($258.53)
$ 321.6724%Add 208.67%19,057
BIIBJohn Hussman 2013-12-31 Sold Out -0.99%$223.85 - $295.88
($258.53)
$ 321.6724%Sold Out0
BIIBVanguard Health Care Fund 2013-12-31 Reduce-0.47%$223.85 - $295.88
($258.53)
$ 321.6724%Reduce -39.09%884,000
BIIBAndreas Halvorsen 2013-12-31 Sold Out -0.39%$223.85 - $295.88
($258.53)
$ 321.6724%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIIB is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BIIB Ken Fisher 2014-06-3088,8850.040.06+386.61%
BIIB Ron Baron 2014-06-308,63200.01+41.76%
BIIB Mario Gabelli 2014-06-304,17500.01+16.46%
BIIB Frank Sands 2014-06-304,891,4632.073.9+0.38%
BIIB PRIMECAP Management 2014-06-3017,258,3117.316-1.39%
BIIB Vanguard Health Care Fund 2014-06-30559,7000.240.47-6.62%
BIIB George Soros 2014-06-30000Sold Out
BIIB Joel Greenblatt 2014-06-30000Sold Out
BIIB John Burbank 2014-06-30000Sold Out
BIIB Andreas Halvorsen 2014-06-30000Sold Out
BIIB Ken Heebner 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


BIIB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Holtzman Steven HEVP Corporate Development 2014-10-01Sell1,750$330.97-2.81view
SCANGOS GEORGE ACEO 2014-10-01Sell1,127$330.97-2.81view
SCANGOS GEORGE ACEO 2014-09-02Sell1,128$345.47-6.89view
SCANGOS GEORGE ACEO 2014-08-01Sell1,128$332.93-3.38view
SCANGOS GEORGE ACEO 2014-07-16Sell12,316$312.372.98view
Posner Brian SDirector 2014-06-20Sell605$3152.12view
Posner Brian SDirector 2014-06-13Sell700$310.53.6view
SCANGOS GEORGE ACEO 2014-06-02Sell484$318.930.86view
Holtzman Steven HEVP Corporate Development 2014-05-19Sell1,221$289.1511.25view
SCANGOS GEORGE ACEO 2014-05-01Sell2,123$285.5612.65view

Press Releases about BIIB :

Quarterly/Annual Reports about BIIB:

News about BIIB:

Articles On GuruFocus.com
Ebola Diagnosis in U.S. Raises Pharmaceutical Stock by 20% Oct 01 2014 
A Few Reasons Why AbbVie's Momentum Will Continue Sep 25 2014 
Baxter Will Remain Diversified and With Competitive Advantages Sep 02 2014 
Ken Fisher's Top Increaes of the Second Quarter Jul 28 2014 
Ken Fisher's Top Increases of the First Quarter Apr 22 2014 
Weekly 52-Week Highs Highlight: ORLY, LLL, BIIB, NVS Feb 09 2014 
Weekly CFO Sells Highlight: CSOD, UTX, MEMS, SBAC, BIIB Sep 22 2013 
PRIMECAP Trims Top Biotechs and More Aug 30 2013 
Edward Owens’ Vanguard Health Care Fund Does More Shedding than Adding in Third Quarter Nov 01 2012 
52-Week High Guru Stocks: BIIB, GE, BDX, IR, PFE Sep 24 2012 


More From Other Websites
Biogen Falls on Concerns Regarding Tecfidera Sales and PML Case Oct 24 2014
Citi, Jefferies Weigh In On Biogen Idec Amid Q3 Earnings Oct 23 2014
Fidelity Biotech Fund Cut Biogen Stake Over Five Months Oct 23 2014
Leading Researchers Join Biogen Idec to Advance Drug Discovery for Neurodegenerative Diseases Oct 23 2014
Leading Researchers Join Biogen Idec to Advance Drug Discovery for Neurodegenerative Diseases Oct 23 2014
US STOCKS-Futures inch up, indicating rebound; earnings awaited Oct 23 2014
US STOCKS-Futures inch up, indicating rebound; earnings awaited Oct 23 2014
Biogen, Thermo Reports Disappoint; Abbott Accelerates Oct 22 2014
Today's Market Thorns, Roses, and All Time Highs... Oct 22 2014
Markets Reverse Early Morning Gains Following Canadian Shooting Oct 22 2014
As earnings season heats up, stocks close on the lows… Oct 22 2014
Major Indexes End Win Streak; Super Micro Surges Oct 22 2014
Stocks Erase Modest Gains; Apple Flirts With Breakout Oct 22 2014
Biogen Idec upgraded by Robert W. Baird Oct 22 2014
Dow Chemical rallies on strong earnings Oct 22 2014
Why Biogen Idec (BIIB) Stock Is Tanking Today Oct 22 2014
Biogen's Q3 Earnings Top Estimates, View Raised Again Oct 22 2014
Stocks Up at Midday; Super Micro Retakes Buy Point Oct 22 2014
Biogen shares fall after Tecfidera patient dies Oct 22 2014
Biogen shares drop on Tecfidera patient death Oct 22 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK